Oxypurinol nephrolithiasis in regional enteritis secondary to allopurinol therapy.
A patient with regional enteritis and recurrent uric acid nephrolithiasis was treated with allopurinol. While on 600 mg of allopurinol daily, she began to pass many small, soft, yellow stones. Analysis of the stones by liquid chromatographic and gas chromatograph/mass spectrometric techniques revealed that their major constituent was oxypurinol, a metabolite of allopurinol. Metabolic studies of the patient indicated that increasing doses of allopurinol were associated with increases in xanthine and oxypurinol excretion, while uric acid excretion was not reduced. This case illustrates a complication of high-dose allopurinol therapy in the treatment of uric acid nephrolithiasis.
D000328:Adult; D000493:Allopurinol / Q000009:adverse effects* / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007669:Kidney Calculi / Q000139:chemically induced* / Q000652:urine; D010117:Oxypurinol / Q000652:urine*; D011743:Pyrimidines / Q000652:urine*; D014527:Uric Acid / Q000652:urine; D014970:Xanthines / Q000652:urine
D011743:Pyrimidines; D014970:Xanthines; D014527:Uric Acid; D000493:Allopurinol; D010117:Oxypurinol